Integrated Clinical-Molecular Risk Stratification in Diffuse Large B-Cell Lymphoma: Machine Learning Survival Analysis
Background The clinical outcomes of diffuse large B-cell lymphoma (DLBCL) are highly heterogeneous. While clinical indices like the international prognostic index (IPI) are widely used, their predictive accuracy remains limited. The integration of molecular features with clinical characteristics holds promise for devel...